![]() |
Volumn 137, Issue 5, 2015, Pages 1738-1741
|
Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H)-one
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIA;
BIOCHEMISTRY;
CELL WALL BIOSYNTHESIS;
FUNCTIONAL ASSAYS;
IN-SILICO;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
PENICILLIN- BINDING PROTEINS;
QUINAZOLINES;
QUINAZOLINONES;
RESISTANT BACTERIA;
ANTIBIOTICS;
3 (3 CARBOXYPHENYL) 2 (4 CYANOSTYRYL)QUINAZOLIN 4 (3H)ONE;
ANTIBIOTIC AGENT;
CIPROFLOXACIN;
FOSFOMYCIN;
LINEZOLID;
MEROPENEM;
PENICILLIN BINDING PROTEIN;
RIFAMPICIN;
TETRACYCLINE;
UNCLASSIFIED DRUG;
VANCOMYCIN;
(E)-3-(3-CARBOXYPHENYL)-2-(4-CYANOSTYRYL)QUINAZOLIN-4(3H)-ONE;
4-HYDROXYQUINAZOLINE;
ANTIINFECTIVE AGENT;
BACTERIAL PROTEIN;
MECA PROTEIN, STAPHYLOCOCCUS AUREUS;
QUINAZOLINONE DERIVATIVE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BINDING SITE;
BIOSYNTHESIS;
COMPARATIVE STUDY;
CROSS LINKING;
CRYSTAL STRUCTURE;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG CONFORMATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SCREENING;
DRUG SYNTHESIS;
ELIMINATION HALF-LIFE;
HUMAN;
HUMAN CELL;
IC50;
IN VITRO STUDY;
IN VIVO STUDY;
MACROMOLECULE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
MOLECULAR DOCKING;
MOUSE;
NONHUMAN;
PROTEIN BINDING;
RAT;
STAPHYLOCOCCUS AUREUS;
VOLUME OF DISTRIBUTION;
BIOAVAILABILITY;
CHEMISTRY;
DRUG DEVELOPMENT;
DRUG EFFECTS;
METABOLISM;
MICROBIAL SENSITIVITY TEST;
MOLECULAR MODEL;
PROTEIN CONFORMATION;
STAPHYLOCOCCUS;
ANTI-BACTERIAL AGENTS;
BACTERIAL PROTEINS;
BIOLOGICAL AVAILABILITY;
DRUG DISCOVERY;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
PENICILLIN-BINDING PROTEINS;
PROTEIN CONFORMATION;
QUINAZOLINONES;
STAPHYLOCOCCUS;
|
EID: 84922762182
PISSN: 00027863
EISSN: 15205126
Source Type: Journal
DOI: 10.1021/jacs.5b00056 Document Type: Article |
Times cited : (118)
|
References (20)
|